----
Closed: Nov 6, 16:00:00 (EDT)US IPO Weekly Recap: Biotech, early-stage mining, and Bill Ackman close out the April IPO market
RenaissanceCapital·- Four IPOs were priced last week, primarily from biotechnology firms, raising significant capital. - Hemab Therapeutics, Avalyn Pharma, and Seaport Therapeutics raised $302 million, $300 million, and $255 million respectively, focusing on various therapeutic areas and reporting substantial stock price increases. - Additionally, 11 SPACs raised $2.2 billion, marking the largest week for such issues since December 2021, with the Renaissance IPO Index up 6.5% year-to-date.Pershing Square Secures $350 Million Senior Credit Facilities to Support PSUS Anchor Investment
TradingView·- Pershing Square announced a $350 million senior secured credit package led by Bank of America, consisting of a $250 million revolving facility and a $100 million term loan, to enhance liquidity and support its anchor investment. - Additionally, the company has finalized two registration rights agreements with investors to facilitate potential future resales, aligning with IPO prospectus disclosures. - These agreements aim to improve capital access and provide trading flexibility following the IPO.
